Skip to main content
Log in

Effectiveness of Bushen Huoxue Granule (补肾活血颗粒) on 5-serotonin and norepinephrine in the brain of Parkinson’s disease patients with depressive state

  • Original Article
  • Published:
Chinese Journal of Integrative Medicine Aims and scope Submit manuscript

Abstract

Objective

To observe the clinical curative effect of Chinese medicine Bushen Huoxue Granule(补肾活血颗粒, BHG) on Parkinson’s disease (PD) patients with depressive state.

Methods

Sixty-two PD patients with depressive state were randomly assigned to two groups by using a random number table, 31 in each group. Madopar was given to all as the conventional treatment. The fluoxetine hydrochloride dispersible tablet was given to the patients in the control group and BHG was given to those in the treatment group. The therapeutic course for all was 12 weeks. Before and after treatment, Hamilton depression rating scale (HAMD) was applied to judge the curative effect, and the changes of cerebral neurotransmitters levels in the brain of patients were detected by encephalofluctuograph technique.

Results

The scores of HAMD in the two groups were decreased markedly after 12-week treatment. It was lower in the treatment group than that in the control group with significant difference (P<0.01). The contents of norepinephrine (NE) and 5-serotonin (5-HT) in the PD patients were obviously lower than normal value. There was no significant difference between the two groups before treatment (P>0.05). The contents of NE and 5-HT were all increased in the two groups after treatment (P<0.05), with significant differences between the two groups (P<0.01).

Conclusion

BHG could increase the contents of NE and 5-HT in PD patients’ brain to improve the depressive state of PD patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Liu CY, Wang SJ, Fuh JI, Lin CH, Yang YY, Lin HC. The correlation of depression with functional activity in Parkinson disease. J Neurol 1997;224:493–498.

    Article  Google Scholar 

  2. Gibb UR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson’s disease. J Neurol Neurosurg Psychiatry 1988;51:745–752.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  3. Nation DA, Katzen H L, Papapetropoulos S. Subthreshold depression in Parkinson’s disease. Int J Geriatr Psychiatry 2011;24:937 943.

    Google Scholar 

  4. Yang MH, Li M, Dou YQ, Liu Y, Luo XD, Chen JZ, et al. Effects of Bushen Huoxue Granule on motor function in patients with Parkinson’s disease: a multicenter, randomized, double-blind and placebo-controlled trial. J Chin Integr Med 2010;8:231–237.

    Article  Google Scholar 

  5. Li JY, Yang MH, Zhao GY, Wang ZF. Application EEG ultra slow fluctuation figure changes in neurotransmitter in the brain of patients with Parkinson’s research. Chin J Difficult Complic Cases (Chin) 2009;1:3–5.

    CAS  Google Scholar 

  6. Yang MH, Wang HM, Liu Y. Effect of Bushen Huoxue Decoction on the orphan receptor and tyrosine hydroxylase in the brain of rats with Parkinson’s disease. Chin J Integr Med 2010;17:43–47.

    Article  CAS  Google Scholar 

  7. Ai HX, Li L, Xu DM, Wang W, Zhang PC, Zhang L, et al. Morroniside of focal cerebral ischemia and reperfusion in rat cortex total antioxidant capacity. Chin J Rehabil Theory Pract (Chin) 2009;15:833–834.

    Google Scholar 

  8. Zheng HY, Zeng SL, Li T. Experimental study of Parkinson’s disease transplanted neuronal survival Salvia miltiorrhiza Injection. Jiangsu Pharmaceut Clin Res (Chin) 2004;12:1–3.

    Google Scholar 

  9. Li X, Zuo DY, Chen JJ, Wu LY. Polygonum multiflorum extract on monoamine neurotransmitters in a mouse model of behavior and striatum of paraquat and maneb content. J Shenyang Pharm Univ (Chin) 2006;23:797–801

    CAS  Google Scholar 

  10. Long R, Du JR, Chen SJ. Angelica lactone free radical scavenging and antioxidant activity. West China J Pharmaceut Sci (Chin) 2010;25:420–422.

    CAS  Google Scholar 

  11. Si QJ, Wang XG. Centipede of atherosclerotic vascular endothelial cell function in rabbits. Pharmacol Clin Chin Mater Med (Chin) 2002;18:28–30.

    Google Scholar 

  12. Huang ZY, Li WZ, Wu XX. Parkinson’s disease patients’ quality of life status and related influencing factors. Hainan Med (Chin) 2011;22:14–16.

    Google Scholar 

  13. Cheng Y, Liu C, Mao C, Qian J, Liu K, Ke G. Social support plays a role in depression in Parkinson’s disease: acrosssection study in a Chinese cohort. Parkinsonism Relat Disord (Chin) 2008;14:43–45.

    Article  Google Scholar 

  14. Pålhagen SE, Ekberg S, Wålinder J, Granérus AK, Granerus G. HMPAO SPECT in Parkinson’s disease (PD) with major depression (MD) before and after antidepressant treatment. J Neuro 2009;256:1510–1518.

    Article  Google Scholar 

  15. Zhao HQ, Duan YY, Liu YG. The role of 5-hydroxytryptamine in suicidal behavior. Shandong Psychiatry (Chin) 2004;17:54–56.

    Google Scholar 

  16. David JB, Paola P. Imaging in Parkinson’s disease: the role of monoamines in behavior. Biol Psychiat 2006;59:908–918.

    Article  Google Scholar 

  17. Quera-Salva MA, Lemoine P, Guilleminault C. Impact of the novel antidepressant agomelatine on disturbed sleep-wake cycles in depressed patients. Human Psychopharmacol 2010;25:222–229.

    Article  CAS  Google Scholar 

  18. Remy P, Doder M, Lees A, Turjanski N, Brooks D. Depression in Parkinson’s disease:loss of dopamine and noradrenaline innervation in the limbic system. Brain 2005;128:1314–1322.

    Article  PubMed  Google Scholar 

  19. Mei L, ed. ET-brain function testing new technology. Beijing: National Defense Industry Press; 1995:1–98.

    Google Scholar 

  20. Dou YQ, Yang MH, Liu Y, Wei ZM. Integrative Medicine Parkinson Disease Control Observation. Chin J Clin Rehabil (Chin) 2006;10:6–8.

    Google Scholar 

  21. Yang MH, Li M, Dou YQ, Liu Y, Luo XD, Chen JZ, et al. Kidney and activating blood particles affect motor function in patients with Parkinson: multi-center, randomized, double-blind, placebo-controlled study. Chin J Integr Med 2010;18:31–37.

    Google Scholar 

  22. Yang MH, Wang HM, Liu Y. Kidney and activating blood drinking rotation behavior and brain M5 receptor mRNA expression of Parkinson’s disease in rats. Chin J Diffic Complic Cases (Chin) 2008;7:577–579.

    Google Scholar 

  23. Liu MH, Wang HM, Liu Y. Kidney and activating blood to drink a the PD rat tyrosine hydroxylase (TH) and the orphan nuclear receptor (the silencing effects of Nurr1) mRNA impact. Chin J Integr Tradit West Med Intens Critic Care (Chin) 2009;16:72–74.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ming-hui Yang  (杨明会).

Additional information

Supported by the National Natural Science Foundation of China (No. 30672762)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, Hm., Yang, Mh., Liu, Y. et al. Effectiveness of Bushen Huoxue Granule (补肾活血颗粒) on 5-serotonin and norepinephrine in the brain of Parkinson’s disease patients with depressive state. Chin. J. Integr. Med. 20, 944–948 (2014). https://doi.org/10.1007/s11655-014-2029-6

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11655-014-2029-6

Keywords

Navigation